Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)
NCT02463305
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
inability to enroll
Conditions
Colitis, Ulcerative
Interventions
DRUG:
Creatine monohydrate
OTHER:
Placebo
Sponsor
University of Colorado, Denver